Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Macchini

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
La Radiologia Medica|June 1, 1993
[Stereotaxic breast microhistology]M Macchini, L Baffoni, S Natale, et al.
La Radiologia Medica|July 1, 1989
[The factor of magnification in mammography]S Maggi, G M Giuseppetti, G Spiga, et al.
Journal of Endocrinological Investigation|July 1, 1980
Effects fo streptozotocin in the WDHA syndrome not amenable to radical surgeryG Biliotti, C Masi, M Macchini, et al.
Journal of Endocrinological Investigation|July 1, 1980
Effects of streptozotocin in the WDHA syndrome not amenable to radical surgeryG Biliotti, C Masi, M Macchini, et al.
Diagnostic and Interventional Imaging|April 7, 2019
Percutaneous transluminal angioplasty alone versus stent placement for the treatment of transplant renal artery stenosisM Macchini, T Mokrane, J Darcourt, et al.
Emergency Radiology|July 22, 2023
Predictive factors of selective transarterial embolization failure in acute renal bleeding: a single-center experienceC Floridi, L M Cacioppa, N Rossini, et al.
ESMO Open|July 16, 2022
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447]S Ochsenreither, W M Fiedler, G Del Conte, et al.
ESMO Open|April 9, 2022
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumorsS Ochsenreither, W M Fiedler, G D Conte, et al.
ESMO Open|January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)M Reni, M Milella, F Bergamo, et al.
ESMO Open|February 2, 2023
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI surveyM Reni, E Giommoni, F Bergamo, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
La Radiologia Medica|June 1, 1993
[Stereotaxic breast microhistology]M Macchini, L Baffoni, S Natale, et al.
La Radiologia Medica|July 1, 1989
[The factor of magnification in mammography]S Maggi, G M Giuseppetti, G Spiga, et al.
Journal of Endocrinological Investigation|July 1, 1980
Effects fo streptozotocin in the WDHA syndrome not amenable to radical surgeryG Biliotti, C Masi, M Macchini, et al.
Journal of Endocrinological Investigation|July 1, 1980
Effects of streptozotocin in the WDHA syndrome not amenable to radical surgeryG Biliotti, C Masi, M Macchini, et al.
Diagnostic and Interventional Imaging|April 7, 2019
Percutaneous transluminal angioplasty alone versus stent placement for the treatment of transplant renal artery stenosisM Macchini, T Mokrane, J Darcourt, et al.
Emergency Radiology|July 22, 2023
Predictive factors of selective transarterial embolization failure in acute renal bleeding: a single-center experienceC Floridi, L M Cacioppa, N Rossini, et al.
ESMO Open|July 16, 2022
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447]S Ochsenreither, W M Fiedler, G Del Conte, et al.
ESMO Open|April 9, 2022
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumorsS Ochsenreither, W M Fiedler, G D Conte, et al.
ESMO Open|January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)M Reni, M Milella, F Bergamo, et al.
ESMO Open|February 2, 2023
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI surveyM Reni, E Giommoni, F Bergamo, et al.
Pageof 3